These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 22213288)

  • 1. Combinations of resveratrol, cisplatin and oxaliplatin applied to human ovarian cancer cells.
    Nessa MU; Beale P; Chan C; Yu JQ; Huq F
    Anticancer Res; 2012 Jan; 32(1):53-9. PubMed ID: 22213288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on combination of platinum drugs cisplatin and oxaliplatin with phytochemicals anethole and curcumin in ovarian tumour models.
    Nessa MU; Beale P; Chan C; Yu JQ; Huq F
    Anticancer Res; 2012 Nov; 32(11):4843-50. PubMed ID: 23155250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on combinations of platinum with paclitaxel and colchicine in ovarian cancer cell lines.
    Yunos NM; Beale P; Yu JQ; Strain D; Huq F
    Anticancer Res; 2010 Oct; 30(10):4025-37. PubMed ID: 21036717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergism from combinations of cisplatin and oxaliplatin with quercetin and thymoquinone in human ovarian tumour models.
    Nessa MU; Beale P; Chan C; Yu JQ; Huq F
    Anticancer Res; 2011 Nov; 31(11):3789-97. PubMed ID: 22110201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of a monofunctional platinum compound and its activity alone and in combination with phytochemicals in ovarian tumor models.
    Arzuman L; Beale P; Yu JQ; Proschogo N; Huq F
    Anticancer Res; 2014 Dec; 34(12):7077-90. PubMed ID: 25503135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combinations of platinums and selected phytochemicals as a means of overcoming resistance in ovarian cancer.
    Huq F; Yu JQ; Beale P; Chan C; Arzuman L; Nessa MU; Mazumder ME
    Anticancer Res; 2014 Jan; 34(1):541-5. PubMed ID: 24403514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergism from combination of cisplatin and a trans-platinum compound in ovarian cancer cell lines.
    Alshehri A; Beale P; Yu JQ; Huq F
    Anticancer Res; 2010 Nov; 30(11):4547-53. PubMed ID: 21115904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergism from sequenced combinations of curcumin and epigallocatechin-3-gallate with cisplatin in the killing of human ovarian cancer cells.
    Yunos NM; Beale P; Yu JQ; Huq F
    Anticancer Res; 2011 Apr; 31(4):1131-40. PubMed ID: 21508356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Costunolide induces apoptosis in platinum-resistant human ovarian cancer cells by generating reactive oxygen species.
    Yang YI; Kim JH; Lee KT; Choi JH
    Gynecol Oncol; 2011 Dec; 123(3):588-96. PubMed ID: 21945308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination of Genistein and Cisplatin with Two Designed Monofunctional Platinum Agents in Human Ovarian Tumour Models.
    Arzuman L; Beale P; Proschogo N; Yu JQ; Huq F
    Anticancer Res; 2015 Nov; 35(11):6027-39. PubMed ID: 26504026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergism from the combination of oxaliplatin with selected phytochemicals in human ovarian cancer cell lines.
    Yunos NM; Beale P; Yu JQ; Huq F
    Anticancer Res; 2011 Dec; 31(12):4283-9. PubMed ID: 22199293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of topotecan for extending the platinum-free interval in recurrent ovarian cancer: an in vitro model.
    Horowitz NS; Hua J; Gibb RK; Mutch DG; Herzog TJ
    Gynecol Oncol; 2004 Jul; 94(1):67-73. PubMed ID: 15262121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of trans-bis-(2-hydroxypyridine)dichloroplatinum(II) and its activity in human ovarian tumour models.
    Deqnah N; Yu JQ; Beale P; Fisher K; Huq F
    Anticancer Res; 2012 Jan; 32(1):135-40. PubMed ID: 22213298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergism from combinations of tris(benzimidazole) monochloroplatinum(II) chloride with capsaicin, quercetin, curcumin and cisplatin in human ovarian cancer cell lines.
    Arzuman L; Beale P; Chan C; Yu JQ; Huq F
    Anticancer Res; 2014 Oct; 34(10):5453-64. PubMed ID: 25275041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in the in vitro activity of platinum drugs when administered in two aliquots.
    Al-Eisawi Z; Beale P; Chan C; Yu JQ; Proschogo N; Molloy M; Huq F
    BMC Cancer; 2016 Aug; 16(1):688. PubMed ID: 27566066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigallocatechin gallate acts synergistically in combination with cisplatin and designed trans-palladiums in ovarian cancer cells.
    Mazumder ME; Beale P; Chan C; Yu JQ; Huq F
    Anticancer Res; 2012 Nov; 32(11):4851-60. PubMed ID: 23155251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monofunctional Platinum-containing Pyridine-based Ligand Acts Synergistically in Combination with the Phytochemicals Curcumin and Quercetin in Human Ovarian Tumour Models.
    Arzuman L; Beale P; Yu JQ; Huq F
    Anticancer Res; 2015 May; 35(5):2783-94. PubMed ID: 25964558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and antitumour activity of a new trinuclear platinum compound [{cis-PtCl(NH3)2μ {trans-Pt(3-hydroxypyridine)2H2N(CH2)5NH2)2}] Cl4 in human ovarian cancer cells.
    Hamad SA; Beale P; Yu JQ; Huq F
    Anticancer Res; 2014 Apr; 34(4):1923-9. PubMed ID: 24692727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and activity of a trinuclear platinum complex: [{trans-PtCl(NH3)2}2mu-{trans-Pt(3-hydroxypyridine)2(H2N(CH2)6NH2)2}]Cl4 in ovarian cancer cell lines.
    Tayyem H; Huq F; Yu JQ; Beale P; Fisher K
    ChemMedChem; 2008 Jan; 3(1):145-51. PubMed ID: 17963210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-proliferative and pro-apoptotic effects from sequenced combinations of andrographolide and cisplatin on ovarian cancer cell lines.
    Yunos NM; Mutalip SS; Jauri MH; Yu JQ; Huq F
    Anticancer Res; 2013 Oct; 33(10):4365-71. PubMed ID: 24123004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.